Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin
PLOS Pathogens · 2024
DOI: 10.1371/journal.ppat.1011912 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2024. Verfasst von Yuhang Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America. Hauptthemen laut MEDLINE: Bone Marrow Stromal Antigen 2, COVID-19. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Rochester Research Award, Empire State Development NYFirst, School of Medicine and Dentistry, University of Rochester.
Abstract (Originalsprache)
BST2/Tetherin is a restriction factor with broad antiviral activity against enveloped viruses, including coronaviruses. Specifically, BST2 traps nascent particles to membrane compartments, preventing their release and spread. In turn, viruses have evolved multiple mechanisms to counteract BST2. Here, we examined the interactions between BST2 and SARS-CoV-2. Our study shows that BST2 reduces SARS-CoV-2 virion release. However, the virus uses the Spike (S) protein to downregulate BST2. This requires a physical interaction between S and BST2, which routes BST2 for lysosomal degradation in a Clathtin- and ubiquitination-dependent manner. By surveying different SARS-CoV-2 variants of concern (Alpha-Omicron), we found that Omicron is more efficient at counteracting BST2, and that mutations in S account for its enhanced anti-BST2 activity. Mapping analyses revealed that several surfaces in the extracellular region of BST2 are required for an interaction with the Spike, and that the Omicron variant has changed its patterns of association with BST2 to improve its counteraction. Therefore, our study suggests that, besides enhancing receptor binding and evasion of neutralizing antibodies, mutations accumulated in the Spike afford more efficient counteraction of BST2, which highlights that BST2 antagonism is important for SARS-CoV-2 infectivity and spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York, United States of America.
ORCID-Profile: Ruth Serra-Moreno
Förderung
- University of Rochester Research Award
- Empire State Development NYFirst
- School of Medicine and Dentistry, University of Rochester
- Empire State Development
Zitieren
APA
Shi, Y., Simpson, S., Chen, Y., Aull, H., Benjamin, J., & Serra-Moreno, R. (2024). Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1011912
Vancouver
Shi Y, Simpson S, Chen Y, Aull H, Benjamin J, Serra-Moreno R. Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin. PLOS Pathogens. 2024. doi:10.1371/journal.ppat.1011912
BibTeX
@article{Shi2024,
author = {Shi, Yuhang and Simpson, Sydney and Chen, Yuexuan and Aull, Haley and Benjamin, Jared and Serra-Moreno, Ruth},
title = {Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin},
journal = {PLOS Pathogens},
year = {2024},
doi = {10.1371/journal.ppat.1011912}
}
EUVIMED